99 results match your criteria: "Center for Cardiovascular Research and Development[Affiliation]"
JACC Case Rep
August 2024
Division of Cardiac, Thoracic & Vascular Surgery, New York-Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA.
Valve-in-valve transcatheter aortic valve replacement for failed Perceval sutureless valves has been shown to be safe and feasible. However, it is technically challenging and warrants understanding of potential risks and complications. We present a case of successful valve-in-valve implantation complicated by inadvertent wire passage outside of the Perceval frame.
View Article and Find Full Text PDFPathogens
June 2024
Division of Cardiac, Thoracic & Vascular Surgery, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY 10032, USA.
Neuromolecular Med
July 2024
Department of Pediatric Neurosurgery, Medical University of Silesia, Katowice, Poland.
Adamantinomatous craniopharyngioma (ACP) is an intracranial tumor considered partly malignant due to its ability to infiltrate surrounding structures and tendency to relapse despite radical resection. CD44 is a known stem cell marker in ACP and is upregulated in cell clusters of invasive ACP protrusions; however, the functions of its alternative splicing isoform variants, CD44s and CD44v1-10, have not yet been studied in terms of ACP recurrence, despite their confirmed roles in cancer development and progression. In this study, we first confirmed the difference in total CD44 expression between samples from patients who experienced relapse and those from patients who did not.
View Article and Find Full Text PDFBraz J Cardiovasc Surg
February 2024
Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland.
Introduction: The evidence for using del Nido cardioplegia protocol in high-risk patients with reduced ejection fraction undergoing isolated coronary surgery is insufficient.
Methods: The institutional database was searched for isolated coronary bypass procedures. Patients with ejection fraction < 40% were selected.
Bioengineering (Basel)
December 2023
Mayo Clinic, Rochester, MN 55905, USA.
Epicardial pulsed field ablation (PFA) of ganglionated plexi (GPs) is being explored as a potential treatment for atrial fibrillation. Initial work using open-chest access with a monopolar ablation device has been completed. This study describes the early development work for a device that can be used with subxiphoid access and deliver bipolar ablation pulses.
View Article and Find Full Text PDFJACC Case Rep
November 2023
Division of Cardiology, New York Presbyterian Hospital-Columbia University Medical Center, New York, New York, USA.
Mitral valve replacement in the setting of extensive mitral annular calcification is technically challenging and associated with high mortality and morbidity, including stroke. This is the first published report of direct surgical transcatheter valve implantation with use of a cerebral embolic protection device. ().
View Article and Find Full Text PDFSci Rep
September 2023
Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
Median sternotomy is the surgical method of choice for many procedures where one of the main problems is the long post-operative wound healing process leading to sternal dehiscence and the development of infection. This leads to prolonged hospital stay and increased mortality due to post-operative complications. A promising solution seems to be the use of allogeneic chondrocytes for wound treatment, whose properties in the field of cartilage reconstruction are widely used in medicine, mainly in orthopedics.
View Article and Find Full Text PDFJ Cardiol
March 2024
CRF Skirball Center for Innovation, Orangeburg, NY, USA. Electronic address:
Background: As the catheter-based device closure of the patent foramen ovale (PFO) is expanding, novel devices aim to address the limitations of first-generation occluders (e.g. bulk, erosion, dislodgment).
View Article and Find Full Text PDFCardiol J
March 2024
American Heart of Poland, Center for Cardiovascular Research and Development, Katowice, Poland.
Background: The aim of the study was to evaluate bio-functionality of a novel, proprietary balloon-expandable biological transcatheter aortic valve implantation (TAVI) system (InFlow, CardValve Consortium, Poland) in an ovine model of aortic banding.
Methods: Surgical ascending aorta banding was created in 21 sheep. Two weeks later, 18 biological valves were implanted within the model using 15-16 F InFlow TAVI systems and carotid cut-down approach.
Thorac Cardiovasc Surg
October 2024
Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland.
Background: Perioperative cardioprotection is essential for achieving satisfactory clinical outcomes in heart failure patients. It is important to understand the factors affecting perioperative cardioprotection.
Methods: The institutional database was searched for patients with reduced ejection fraction (EF, < 40%) who underwent surgery with cardioplegia-induced arrest.
Postepy Kardiol Interwencyjnej
June 2023
Department of Cardiology, American Heart of Poland, Bielsko-Biała, Poland.
The coronavirus disease 2019 (COVID-19) pandemic significantly increased mortality worldwide. However, only part of the excess mortality is related directly to the infection. Local healthcare accessibility, time to reach medical care and patients' reluctance to seek medical aid strongly affected the treatment results in many fields.
View Article and Find Full Text PDFDiagnostics (Basel)
June 2023
First Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 02-097 Warsaw, Poland.
Today, coronary artery disease (CAD) continues to be a prominent cause of death worldwide. A reliable assessment of coronary stenosis represents a prerequisite for the appropriate management of CAD. Nevertheless, there are still major challenges pertaining to some limitations of current imaging and functional diagnostic modalities.
View Article and Find Full Text PDFInt J Cardiol
October 2023
Medical University of Silesia, Epidemiology Department, Katowice, Poland.
Background: Although infective endocarditis (IE) represents a unique model of thrombo-inflammatory disease, the most frequent early complications of surgical valve replacement (SVR) in IE population are coagulopathy and bleeding. The hemostatic capacity and procedure-related coagulation disorders of IE patients undergoing SVR are unknown. The aims of this study were to test periprocedural hemostasis in IE patients undergoing urgent SVR, and to assess the association between disorders of hemostasis and early bleeding as well as with thromboembolic events.
View Article and Find Full Text PDFKardiol Pol
April 2023
Department of Cardiology, Andrzej Frycz Modrzewski Krakow University, Bielsko-Biała, Poland.
Background: The Coordinated Care in Myocardial Infarction Program (KOS-MI) was introduced to improve prognosis for patients after myocardial infarction (MI). The program includes complete revascularization followed by unrestricted access to rehabilitation, electrotherapy, and cardiac care.
Aim: This study aimed to assess major adverse cardiac and cerebrovascular events (MACCE) of patients enrolled in the KOS-MI at 3-year follow-up.
Kardiochir Torakochirurgia Pol
March 2023
Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biala, Poland.
Front Cardiovasc Med
March 2023
Division of Cardiothoracic Surgery, New York Presbyterian Hospital, College of Physicians and Surgeons of Columbia University, New York, NY, United States.
Valvular heart disease is an important source of cardiovascular morbidity and mortality. Current prosthetic valve replacement options, such as bioprosthetic and mechanical heart valves are limited by structural valve degeneration requiring reoperation or the need for lifelong anticoagulation. Several new polymer technologies have been developed in recent years in the hope of creating an ideal polymeric heart valve substitute that overcomes these limitations.
View Article and Find Full Text PDFKardiol Pol
June 2023
Department of Cardiac Surgery, University Hospital, Institute of Medical Sciences, University of Opole, Opole, Poland.
Background: The evidence on performing minimally invasive coronary artery surgery early after drug-eluting stent (DES) implantation due to acute coronary syndrome (ACS) is limited.
Aim: The study aimed to determine the safety and feasibility of this approach.
Methods: This registry included 115 (78% male) patients treated from 2013 to 2018, who underwent non-left anterior descending (LAD) percutaneous coronary intervention (PCI) due to ACS with contemporary DES implantation (39% diagnosed with myocardial infarction at baseline), followed by endoscopic atraumatic coronary artery bypass (EACAB) surgery within 180 days, after temporary P2Y12 inhibitor discontinuation.
Pol Arch Intern Med
September 2023
Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
Introduction: Smoking is a well‑established risk factor for cardiovascular diseases. However, in patients with ST‑segment elevation myocardial infarction (STEMI), smoking has been associated with better clinical outcomes; this phenomenon became known as the "smoker's paradox."
Objectives: The aim of this study was to evaluate the association between smoking and clinical outcomes in STEMI patients treated with primary percutaneous coronary intervention (PCI), using 3 large national registries.
Biomedicines
January 2023
Center for Cardiovascular Research and Development, American Heart of Poland, 40-028 Katowice, Poland.
Ischemic heart disease (IHD) is one of the main focuses in today's healthcare due to its implications and complications, and it is predicted to be increasing in prevalence due to the ageing population. Although the conventional pharmacological and interventional methods for the treatment of IHD presents with success in the clinical setting, the long-term complications of cardiac insufficiency are on a continual incline as a result of post-infarction remodeling of the cardiac tissue. The migration and involvement of stem cells to the cardiac muscle, followed by differentiation into cardiac myocytes, has been proven to be the natural process, though at a slow rate.
View Article and Find Full Text PDFFront Cardiovasc Med
December 2022
American Heart of Poland, Center for Cardiovascular Research and Development, Katowice, Poland.
Objectives: The aim of the study is to evaluate the functionality, durability, and temporal biocompatibility of a novel, balloon-expandable polymeric transcatheter heart valve (ATHV) system (InFlow, CardValve Consortium, Poland). Along with expanding TAVI indications, the demand for new transcatheter valves is increasing.
Methods: A surgical ascending aortic banding model was created in 20 sheep.
Bioengineering (Basel)
December 2022
Center for Cardiovascular Research and Development, American Heart of Poland, 40-028 Katowice, Poland.
Stem cell treatment is a promising method of therapy for the group of patients whose conventional options for treatment have been limited or rejected. Stem cells have the potential to repair, replace, restore and regenerate cells. Moreover, their proliferation level is high.
View Article and Find Full Text PDFJ Cardiovasc Surg (Torino)
February 2023
Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland.
Background: There is sparse evidence on the efficacy of del Nido cardioplegia in high-risk patients with reduced ejection fraction undergoing valvular or complex heart surgery, and further investigation is required.
Methods: An institutional registry was searched for patients who underwent valvular or complex heart surgery and had an ejection fraction <40%. Subjects who received del Nido cardioplegia (DNC) and cold blood cardioplegia (CBC) were selected.
Perfusion
March 2024
Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland.
Background: There has been increasing interest in using del Nido cardioplegia in adult cardiac surgery. However, there is limited evidence for its efficacy in patients with acute coronary syndrome and reduced ejection fraction.
Methods: This study examined patients with decreased ejection fraction (EF < 40%) who were hospitalized due to acute coronary syndrome and received either del Nido (DN) or cold blood cardioplegia (CB).
Kardiol Pol
February 2023
Department of Cardiology, American Heart of Poland, Bielsko-Biała, Poland.
Background: The collateral damage caused by the COVID-19 pandemic affected cardiovascular disease patients, mainly acute coronary syndrome (ACS) cases. Additionally, lockdown caused treatment-related concerns and reluctance to seek medical help, factors that can delay treatment.
Aim: We aimed to analyze the incidence and course of ACS after the first COVID-19 wave.
Front Cardiovasc Med
October 2022
Department of Epidemiology, Medical University of Silesia, Katowice, Poland.
Background: The constant growth of interest in hybrid coronary artery revascularization (HCR) is apparent. Yet, few studies report outcomes of the one-stage HCR. Consequently, the status of such procedures is not adequately supported in clinical guidelines.
View Article and Find Full Text PDF